Allergy and Asthma Proceedings

Papers
(The H4-Index of Allergy and Asthma Proceedings is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination66
Association of EDN levels in patients with asthma and correlation with FEV1%: A meta-analysis56
COVID-19: A continuing challenge for the allergist/immunologist35
Biomarker underuse contributes to an inability to phenotype patients with severe uncontrolled asthma28
Not all marketed skin cleansers’ pH is optimal for atopic dermatitis27
Future directions in allergen immunotherapy27
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study24
Health-related quality of life in children with hereditary angioedema compared with patients with histaminergic angioedema23
The role of component-resolved diagnosis in Hymenoptera venom allergy in clinical practice23
Meteorological and environmental factors that impact pollen counts, allergenicity, and thresholds: A scoping review20
Venom allergen immunotherapy20
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol18
Predictors of anaphylaxis to peanut and tree nuts in a Mediterranean population18
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery18
Safety of ciclesonide in children with asthma: A review of randomized controlled trials18
For the Patient18
For the Patient18
Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis17
0.092695951461792